277 related articles for article (PubMed ID: 25281746)
1. Streptococcus pneumoniae phosphoglycerate kinase is a novel complement inhibitor affecting the membrane attack complex formation.
Blom AM; Bergmann S; Fulde M; Riesbeck K; Agarwal V
J Biol Chem; 2014 Nov; 289(47):32499-511. PubMed ID: 25281746
[TBL] [Abstract][Full Text] [Related]
2. Recombinant C345C and factor I modules of complement components C5 and C7 inhibit C7 incorporation into the complement membrane attack complex.
Thai CT; Ogata RT
J Immunol; 2005 May; 174(10):6227-32. PubMed ID: 15879120
[TBL] [Abstract][Full Text] [Related]
3. Enolase of Streptococcus pneumoniae binds human complement inhibitor C4b-binding protein and contributes to complement evasion.
Agarwal V; Hammerschmidt S; Malm S; Bergmann S; Riesbeck K; Blom AM
J Immunol; 2012 Oct; 189(7):3575-84. PubMed ID: 22925928
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal phosphoglycerate kinase interacts with plasminogen and its tissue activator.
Fulde M; Bernardo-García N; Rohde M; Nachtigall N; Frank R; Preissner KT; Klett J; Morreale A; Chhatwal GS; Hermoso JA; Bergmann S
Thromb Haemost; 2014 Mar; 111(3):401-16. PubMed ID: 24196407
[TBL] [Abstract][Full Text] [Related]
5. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing.
Joiner K; Brown E; Hammer C; Warren K; Frank M
J Immunol; 1983 Feb; 130(2):845-9. PubMed ID: 6848598
[TBL] [Abstract][Full Text] [Related]
6. Binding of Streptococcus pneumoniae endopeptidase O (PepO) to complement component C1q modulates the complement attack and promotes host cell adherence.
Agarwal V; Sroka M; Fulde M; Bergmann S; Riesbeck K; Blom AM
J Biol Chem; 2014 May; 289(22):15833-44. PubMed ID: 24739385
[TBL] [Abstract][Full Text] [Related]
7. Calcium-loaded erythrocytes have a defect in complement regulation distinct from that resulting from exposure to 2-aminoethylisothiouronium bromide.
Test ST; Mitsuyoshi J
Blood; 1995 Oct; 86(7):2799-806. PubMed ID: 7545473
[TBL] [Abstract][Full Text] [Related]
8. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
Milis L; Morris CA; Sheehan MC; Charlesworth JA; Pussell BA
Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159
[TBL] [Abstract][Full Text] [Related]
9. Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes.
Fernie-King BA; Seilly DJ; Willers C; Würzner R; Davies A; Lachmann PJ
Immunology; 2001 Jul; 103(3):390-8. PubMed ID: 11454069
[TBL] [Abstract][Full Text] [Related]
10. Identification of the actin and plasminogen binding regions of group B streptococcal phosphoglycerate kinase.
Boone TJ; Tyrrell GJ
J Biol Chem; 2012 Aug; 287(34):29035-44. PubMed ID: 22761440
[TBL] [Abstract][Full Text] [Related]
11. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
Podack ER; Tschoop J; Müller-Eberhard HJ
J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
Brannen CL; Sodetz JM
Mol Immunol; 2007 Feb; 44(5):960-5. PubMed ID: 16624411
[TBL] [Abstract][Full Text] [Related]
13. Membrane attack by complement.
Podack ER; Tschopp J
Mol Immunol; 1984 Jul; 21(7):589-603. PubMed ID: 6379417
[TBL] [Abstract][Full Text] [Related]
14. Streptococcus pneumoniae endopeptidase O (PepO) is a multifunctional plasminogen- and fibronectin-binding protein, facilitating evasion of innate immunity and invasion of host cells.
Agarwal V; Kuchipudi A; Fulde M; Riesbeck K; Bergmann S; Blom AM
J Biol Chem; 2013 Mar; 288(10):6849-63. PubMed ID: 23341464
[TBL] [Abstract][Full Text] [Related]
15. Tuf of Streptococcus pneumoniae is a surface displayed human complement regulator binding protein.
Mohan S; Hertweck C; Dudda A; Hammerschmidt S; Skerka C; Hallström T; Zipfel PF
Mol Immunol; 2014 Nov; 62(1):249-64. PubMed ID: 25046156
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen is a complement inhibitor.
Barthel D; Schindler S; Zipfel PF
J Biol Chem; 2012 May; 287(22):18831-42. PubMed ID: 22451663
[TBL] [Abstract][Full Text] [Related]
17. Interference of the Zika Virus E-Protein With the Membrane Attack Complex of the Complement System.
Malekshahi Z; Schiela B; Bernklau S; Banki Z; Würzner R; Stoiber H
Front Immunol; 2020; 11():569549. PubMed ID: 33193347
[TBL] [Abstract][Full Text] [Related]
18. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
Joiner KA; Hammer CH; Brown EJ; Cole RJ; Frank MM
J Exp Med; 1982 Mar; 155(3):797-808. PubMed ID: 6801179
[TBL] [Abstract][Full Text] [Related]
19. Complement component C7 is a plasminogen-binding protein.
Reinartz J; Hänsch GM; Kramer MD
J Immunol; 1995 Jan; 154(2):844-50. PubMed ID: 7814888
[TBL] [Abstract][Full Text] [Related]
20. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
Rosenfeld SI; Jenkins DE; Leddy JP
J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
